{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T19:06:24Z","timestamp":1775934384885,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.neulet.2013.04.051","type":"journal-article","created":{"date-parts":[[2013,5,9]],"date-time":"2013-05-09T19:01:04Z","timestamp":1368126064000},"page":"37-41","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Proton magnetic resonance spectroscopy measures related to short-term symptomatic outcome in chronic schizophrenia"],"prefix":"10.1016","volume":"547","author":[{"given":"Agata","family":"Szulc","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beata","family":"Konarzewska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beata","family":"Galinska-Skok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna","family":"Lazarczyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Napoleon","family":"Waszkiewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugeniusz","family":"Tarasow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Milewski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerzy","family":"Walecki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neulet.2013.04.051_bib0005","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1001\/archpsyc.1997.01830220085012","article-title":"Measurement of glutamate and glutamine in the medial prefrontal cortex of never-treated schizophrenic patients and healthy controls by proton magnetic resonance spectroscopy","volume":"54","author":"Bartha","year":"1997","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neulet.2013.04.051_bib0010","series-title":"Psychotropic Drug Directory 2003\/04: The Professional's Pocket Handbook and Aide Memoire","author":"Bazire","year":"2003"},{"key":"10.1016\/j.neulet.2013.04.051_bib0015","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.biopsych.2010.10.004","article-title":"Proton magnetic resonance spectroscopy and illness stage in schizophrenia \u2013 a systematic review and meta-analysis","volume":"69","author":"Brugger","year":"2011","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neulet.2013.04.051_bib0020","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1176\/appi.ajp.160.11.2063","article-title":"Early prediction of antipsychotic response in schizophrenia","volume":"160","author":"Correll","year":"2003","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neulet.2013.04.051_bib0025","doi-asserted-by":"crossref","DOI":"10.1038\/npp.2012.113","article-title":"Anterior cingulate glutamate levels related to clinical status following treatment in first-episode schizophrenia","author":"Egerton","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neulet.2013.04.051_bib0030","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.4088\/JCP.v67n1106","article-title":"Remission in first-episode psychosis: predictor variables and symptom improvement patterns","volume":"67","author":"Emsley","year":"2006","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.neulet.2013.04.051_bib0035","series-title":"Structured Clinical Interview for DSM-IV Axis I Disorders: SCID \u2013 I: Clinician Version: Administration Booklet","author":"First","year":"1997"},{"key":"10.1016\/j.neulet.2013.04.051_bib0040","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1001\/archgenpsychiatry.2011.1472","article-title":"Predicting psychosis: meta-analysis of transition outcomes in individuals at high clinical risk","volume":"69","author":"Fusar-Poli","year":"2012","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neulet.2013.04.051_bib0045","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1093\/schbul\/sbr134","article-title":"Neuroanatomical maps of psychosis onset: voxel-wise meta-analysis of antipsychotic-naive VBM studies","volume":"38","author":"Fusar-Poli","year":"2012","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neulet.2013.04.051_bib0050","first-page":"CR82","article-title":"Duration of untreated psychosis and proton magnetic resonance spectroscopy (1H MRS) findings in first-episode schizophrenia","volume":"15","author":"Galinska","year":"2009","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.neulet.2013.04.051_bib0055","series-title":"ECDEU Assessment Manual for Psychopathology","first-page":"534","author":"Guy","year":"1976"},{"key":"10.1016\/j.neulet.2013.04.051_bib0060","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/j.pnpbp.2009.07.025","article-title":"Gray matter morphology and the level of functioning in one-year follow-up of first-episode schizophrenia patients","volume":"33","author":"Kasparek","year":"2009","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neulet.2013.04.051_bib0065","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neulet.2013.04.051_bib0070","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1002\/nbm.1681","article-title":"In vivo and ex vivo evidence for ketamine-induced hyperglutamatergic activity in the cerebral cortex of the rat: potential relevance to schizophrenia","volume":"24","author":"Kim","year":"2011","journal-title":"NMR Biomed."},{"key":"10.1016\/j.neulet.2013.04.051_bib0075","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1093\/schbul\/sbr069","article-title":"Glutamate in schizophrenia: a focused review and meta-analysis of 1H MRS studies","volume":"39","author":"Marsman","year":"2013","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neulet.2013.04.051_bib0080","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.pnpbp.2005.04.038","article-title":"Hypothesis: minimal changes in neural transmission in schizophrenia: decreased glutamatergic and GABAergic functions in the prefrontal cortex","volume":"29","author":"Ohnuma","year":"2005","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neulet.2013.04.051_bib0085","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.schres.2004.08.021","article-title":"Evidence for glutamatergic neuronal dysfunction in the prefrontal cortex in chronic but not in first-episode patients with schizophrenia: a proton magnetic resonance spectroscopy study","volume":"73","author":"Ohrmann","year":"2005","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neulet.2013.04.051_bib0090","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2147\/CEOR.S16859","article-title":"Cost-effectiveness of early responders versus early nonresponders to atypical antipsychotic therapy","volume":"3","author":"Peng","year":"2011","journal-title":"ClinicoEcon. Outcomes Res."},{"key":"10.1016\/j.neulet.2013.04.051_bib0095","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1016\/j.neubiorev.2012.07.012","article-title":"Multimodal meta-analysis of structural and functional brain changes in first episode psychosis and the effects of antipsychotic medication","volume":"36","author":"Radua","year":"2012","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neulet.2013.04.051_bib0100","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.brainresrev.2003.11.001","article-title":"Magnetic resonance spectroscopy in cognitive research","volume":"44","author":"Ross","year":"2004","journal-title":"Brain Res. Brain Res. Rev."},{"key":"10.1016\/j.neulet.2013.04.051_bib0105","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1176\/appi.ajp.162.2.394","article-title":"Effects of ketamine on anterior cingulate glutamate metabolism in healthy humans: a 4-T proton MRS study","volume":"162","author":"Rowland","year":"2005","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neulet.2013.04.051_bib0110","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1016\/j.jpsychires.2011.07.014","article-title":"Influencing factors and predictors of early improvement in the acute treatment of schizophrenia and schizophrenia spectrum disorder","volume":"45","author":"Schennach-Wolff","year":"2011","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.neulet.2013.04.051_bib0115","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1192\/bjp.bp.109.069328","article-title":"An early improvement threshold to predict response and remission in first-episode schizophrenia","volume":"196","author":"Schennach-Wolff","year":"2010","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.neulet.2013.04.051_bib0120","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1038\/sj.npp.1300850","article-title":"Measurement of brain metabolites by 1H magnetic resonance spectroscopy in patients with schizophrenia: a systematic review and meta-analysis","volume":"30","author":"Steen","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neulet.2013.04.051_bib0125","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.jaac.2012.03.009","article-title":"Glutamatergic effects of divalproex in adolescents with mania: a proton magnetic resonance spectroscopy study","volume":"51","author":"Strawn","year":"2012","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.neulet.2013.04.051_bib0130","first-page":"414","article-title":"Proton magnetic resonance spectroscopy changes after antipsychotic treatment","volume":"20","author":"Szulc","year":"2013","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.neulet.2013.04.051_bib0135","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1055\/s-0031-1279739","article-title":"Proton magnetic resonance spectroscopy study of brain metabolite changes after antipsychotic treatment","volume":"44","author":"Szulc","year":"2011","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.neulet.2013.04.051_bib0140","first-page":"33","article-title":"Glutamatergic system dysfunction in schizophrenia. A proton magnetic resonance spectroscopy (1H MRS) study","volume":"69","author":"Szulc","year":"2004","journal-title":"Pol. J. Radiol."},{"key":"10.1016\/j.neulet.2013.04.051_bib0145","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1176\/appi.ajp.160.12.2231","article-title":"Glutamate and glutamine in the anterior cingulate and thalamus of medicated patients with chronic schizophrenia and healthy comparison subjects measured with 4.0-T proton MRS","volume":"160","author":"Theberge","year":"2003","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neulet.2013.04.051_bib0150","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1176\/appi.ajp.159.11.1944","article-title":"Glutamate and glutamine measured with 4.0T proton MRS in never-treated patients with schizophrenia and healthy volunteers","volume":"159","author":"Theberge","year":"2002","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neulet.2013.04.051_bib0155","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1192\/bjp.bp.106.033670","article-title":"Longitudinal grey-matter and glutamatergic losses in first-episode schizophrenia","volume":"191","author":"Theberge","year":"2007","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.neulet.2013.04.051_bib0160","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1176\/appi.ajp.161.6.1116","article-title":"3-T proton MRS investigation of glutamate and glutamine in adolescents at high genetic risk for schizophrenia","volume":"161","author":"Tibbo","year":"2004","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neulet.2013.04.051_bib0165","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.schres.2011.03.026","article-title":"Prefrontal lobe dysfunction predicts treatment response in medication-naive first-episode schizophrenia","volume":"129","author":"van Veelen","year":"2011","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neulet.2013.04.051_bib0170","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1001\/archpsyc.63.9.969","article-title":"Prediction of functional outcome 18 months after a first psychotic episode: a proton magnetic resonance spectroscopy study","volume":"63","author":"Wood","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neulet.2013.04.051_bib0175","doi-asserted-by":"crossref","first-page":"663","DOI":"10.4088\/JCP.v64n0607","article-title":"Chlorpromazine equivalent doses for the newer atypical antipsychotics","volume":"64","author":"Woods","year":"2003","journal-title":"J. Clin. Psychiatry"}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394013004126?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394013004126?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T03:57:26Z","timestamp":1539662246000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394013004126"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":35,"alternative-id":["S0304394013004126"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2013.04.051","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]}}}